Comparative_JJ
analysis_NN
of_IN
NFAT_NN
-LRB-_-LRB-
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
-RRB-_-RRB-
complex_NN
in_IN
human_JJ
T_NN
and_CC
B_NN
lymphocytes_NNS
._.

Nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
-LRB-_-LRB-
NFAT_NN
-RRB-_-RRB-
is_VBZ
a_DT
transcriptional_JJ
activator_NN
that_WDT
binds_VBZ
to_TO
sequences_NNS
in_IN
the_DT
interleukin-2_NN
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
promoter_NN
and_CC
is_VBZ
thought_VBN
to_TO
be_VB
largely_RB
responsible_JJ
for_IN
the_DT
T_NN
cell-specific_JJ
inducibility_NN
of_IN
IL-2_NN
expression_NN
._.

Electrophoretic_JJ
mobility_NN
shift_NN
assays_NNS
-LRB-_-LRB-
EMSA_NN
-RRB-_-RRB-
showed_VBD
that_IN
specific_JJ
NFAT_NN
binding_NN
activity_NN
could_MD
also_RB
be_VB
induced_VBN
in_IN
human_JJ
B_NN
cells_NNS
._.

The_DT
B_NN
cell_NN
NFAT_NN
complex_NN
,_,
however_RB
,_,
was_VBD
not_RB
functional_JJ
,_,
since_IN
it_PRP
failed_VBD
to_TO
activate_VB
transcription_NN
from_IN
an_DT
NFAT-driven_JJ
chloramphenicol_NN
acetyltransferase_NN
-LRB-_-LRB-
CAT_NN
-RRB-_-RRB-
construct_NN
._.

Competition_NN
with_IN
an_DT
AP-1_NN
motif_NN
or_CC
with_IN
anti-Jun_JJ
and_CC
anti-Fos_JJ
antibodies_NNS
abolished_VBD
binding_NN
to_TO
the_DT
NFAT_NN
motif_NN
in_IN
both_CC
T_NN
and_CC
B_NN
cells_NNS
,_,
indicating_VBG
that_IN
Jun_NN
and_CC
Fos_NN
are_VBP
critical_JJ
for_IN
NFAT_NN
complex_NN
formation_NN
in_IN
both_DT
cell_NN
types_NNS
._.

Purified_VBN
recombinant_JJ
Jun_NN
and_CC
Fos_NN
proteins_NNS
failed_VBD
to_TO
bind_VB
directly_RB
to_TO
the_DT
NFAT_NN
motif_NN
._.

However_RB
,_,
when_WRB
combined_VBN
with_IN
unstimulated_JJ
B_NN
or_CC
T_NN
cell_NN
extracts_NNS
,_,
full-length_JJ
,_,
but_CC
not_RB
truncated_JJ
,_,
Jun\/Fos_NN
heterodimers_NNS
were_VBD
able_JJ
to_TO
form_VB
an_DT
NFAT_NN
complex_NN
,_,
indicating_VBG
the_DT
presence_NN
of_IN
a_DT
constitutively_RB
expressed_VBN
nuclear_JJ
factor_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
in_IN
B_NN
and_CC
T_NN
cells_NNS
necessary_JJ
for_IN
the_DT
formation_NN
of_IN
the_DT
NFAT_NN
complex_NN
in_IN
both_DT
cell_NN
types_NNS
._.

An_DT
NFAT_NN
oligonucleotide_NN
carrying_VBG
mutations_NNS
in_IN
the_DT
5_CD
'_``
purine-rich_JJ
part_NN
of_IN
the_DT
NFAT_NN
sequence_NN
failed_VBD
to_TO
form_VB
a_DT
complex_NN
and_CC
to_TO
compete_VB
with_IN
the_DT
wild_JJ
type_NN
motif_NN
for_IN
NFAT_NN
complex_NN
formation_NN
in_IN
both_CC
T_NN
and_CC
B_NN
cells_NNS
._.

We_PRP
therefore_RB
propose_VBP
a_DT
model_NN
whereby_WRB
a_DT
core_NN
NFAT_NN
complex_NN
consisting_VBG
of_IN
Jun_NN
,_,
Fos_NN
,_,
and_CC
a_DT
constitutive_JJ
nuclear_JJ
factor_NN
is_VBZ
formed_VBN
in_IN
both_CC
T_NN
and_CC
B_NN
cells_NNS
,_,
but_CC
an_DT
additional_JJ
factor_NN
and\/or_CC
post-translational_JJ
modification_NN
of_IN
a_DT
factor_NN
,_,
missing_VBG
in_IN
B_NN
cells_NNS
,_,
might_MD
be_VB
required_VBN
for_IN
transactivation_NN
by_IN
NFAT_NN
._.

